rs115134980
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000203.5(IDUA):c.1402+36T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.162 in 1,392,176 control chromosomes in the GnomAD database, including 19,452 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 2402 hom., cov: 33)
Exomes 𝑓: 0.16 ( 17050 hom. )
Consequence
IDUA
NM_000203.5 intron
NM_000203.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.42
Publications
10 publications found
Genes affected
IDUA (HGNC:5391): (alpha-L-iduronidase) This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008]
IDUA Gene-Disease associations (from GenCC):
- mucopolysaccharidosis type 1Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Myriad Women’s Health
- Scheie syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Orphanet
- Hurler syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia
- Hurler-Scheie syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 4-1002980-T-C is Benign according to our data. Variant chr4-1002980-T-C is described in ClinVar as Benign. ClinVar VariationId is 255522.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.288 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IDUA | NM_000203.5 | c.1402+36T>C | intron_variant | Intron 9 of 13 | ENST00000514224.2 | NP_000194.2 | ||
| IDUA | NM_001363576.1 | c.1006+36T>C | intron_variant | Intron 8 of 12 | NP_001350505.1 | |||
| IDUA | NR_110313.1 | n.1490+36T>C | intron_variant | Intron 9 of 13 | ||||
| IDUA | XM_047415650.1 | c.1402+36T>C | intron_variant | Intron 9 of 11 | XP_047271606.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IDUA | ENST00000514224.2 | c.1402+36T>C | intron_variant | Intron 9 of 13 | 2 | NM_000203.5 | ENSP00000425081.2 |
Frequencies
GnomAD3 genomes AF: 0.175 AC: 26500AN: 151524Hom.: 2406 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
26500
AN:
151524
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.157 AC: 5479AN: 34990 AF XY: 0.169 show subpopulations
GnomAD2 exomes
AF:
AC:
5479
AN:
34990
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.160 AC: 199015AN: 1240546Hom.: 17050 Cov.: 36 AF XY: 0.163 AC XY: 98716AN XY: 605004 show subpopulations
GnomAD4 exome
AF:
AC:
199015
AN:
1240546
Hom.:
Cov.:
36
AF XY:
AC XY:
98716
AN XY:
605004
show subpopulations
African (AFR)
AF:
AC:
5436
AN:
24710
American (AMR)
AF:
AC:
1316
AN:
14828
Ashkenazi Jewish (ASJ)
AF:
AC:
2973
AN:
18962
East Asian (EAS)
AF:
AC:
4352
AN:
27658
South Asian (SAS)
AF:
AC:
16925
AN:
58144
European-Finnish (FIN)
AF:
AC:
5330
AN:
30434
Middle Eastern (MID)
AF:
AC:
961
AN:
4790
European-Non Finnish (NFE)
AF:
AC:
153171
AN:
1009998
Other (OTH)
AF:
AC:
8551
AN:
51022
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
9325
18650
27975
37300
46625
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
5916
11832
17748
23664
29580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.175 AC: 26496AN: 151630Hom.: 2402 Cov.: 33 AF XY: 0.176 AC XY: 13040AN XY: 74122 show subpopulations
GnomAD4 genome
AF:
AC:
26496
AN:
151630
Hom.:
Cov.:
33
AF XY:
AC XY:
13040
AN XY:
74122
show subpopulations
African (AFR)
AF:
AC:
8806
AN:
41372
American (AMR)
AF:
AC:
1888
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
576
AN:
3464
East Asian (EAS)
AF:
AC:
1020
AN:
5098
South Asian (SAS)
AF:
AC:
1445
AN:
4798
European-Finnish (FIN)
AF:
AC:
1737
AN:
10516
Middle Eastern (MID)
AF:
AC:
67
AN:
292
European-Non Finnish (NFE)
AF:
AC:
10413
AN:
67794
Other (OTH)
AF:
AC:
388
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1142
2283
3425
4566
5708
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
290
580
870
1160
1450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
867
AN:
3442
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mucopolysaccharidosis, MPS-I-H/S Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mucopolysaccharidosis, MPS-I-S Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mucopolysaccharidosis type 1 Benign:1
Apr 13, 2018
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Hurler syndrome Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.